Herpes zoster
Clinical trials for Herpes zoster explained in plain language.
Never miss a new study
Get alerted when new Herpes zoster trials appear
Sign up with your email to follow new studies for Herpes zoster, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New shingles vaccine Z-1018 takes on shingrix in Head-to-Head trial
Vaccine OngoingThis study tests a new shingles vaccine called Z-1018 in about 764 healthy adults aged 50 and older. It compares Z-1018 to the current vaccine, Shingrix, to see if it is safe and triggers a strong immune response. The trial is in early phases (1 and 2), so the main focus is on sa…
Matched conditions: HERPES ZOSTER
Phase 1/2 • Sponsor: Dynavax Technologies Corporation • Aim: Vaccine
Last updated Jun 27, 2026 13:00 UTC
-
New shingles vaccine trial aims to protect millions over 40
Vaccine OngoingThis study tests a new shingles vaccine in 960 healthy adults aged 40 and older. The goal is to see if it is safe and triggers a strong immune response. Researchers will monitor side effects and measure antibody levels over time. This is an early-stage trial to help develop a bet…
Matched conditions: HERPES ZOSTER
Phase 1/2 • Sponsor: Ab&B Bio-tech Co., Ltd.JS • Aim: Vaccine
Last updated Jun 27, 2026 12:01 UTC
-
Could this new vaccine stop shingles for years?
Vaccine OngoingThis Phase 3 trial is testing a new shingles vaccine in 12,000 adults aged 40 and older. The goal is to see if the vaccine can prevent shingles for up to 3 years after the two-dose series. Participants previously received the vaccine or a placebo, and researchers are tracking who…
Matched conditions: HERPES ZOSTER
Phase 3 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: Vaccine
Last updated Jun 27, 2026 11:00 UTC
-
New shingles vaccine CRV-101 takes on shingrix in Head-to-Head trial
Vaccine OngoingThis phase 2 study tests a new shingles vaccine called CRV-101 (amezosvatein) against the current standard, Shingrix, in about 1,500 adults aged 50 and older. The goal is to see if CRV-101 is safer and triggers a strong immune response. Participants receive two shots and are moni…
Matched conditions: HERPES ZOSTER
Phase 2 • Sponsor: Curevo Inc • Aim: Vaccine
Last updated Jun 27, 2026 07:53 UTC
-
Shingles pain breakthrough? injections may beat standard drugs
Symptom relief OngoingThis study tests whether injecting a mix of lidocaine and steroids into tender points can better relieve shingles pain compared to standard painkillers alone. The trial involves 136 adults with severe shingles pain for less than 90 days. Researchers will track pain levels for up …
Matched conditions: HERPES ZOSTER
Sponsor: Beijing Tiantan Hospital • Aim: Symptom relief
Last updated Jun 26, 2026 13:48 UTC
-
Shingles vaccine safety in pregnancy under review for immunocompromised women
Knowledge-focused OngoingThis study looks at whether the shingles vaccine (HZ/su) is safe for pregnant women aged 18-49 with weakened immune systems. Researchers will track about 2,800 women to see if the vaccine raises the risk of birth defects or other problems in their babies. The goal is to provide r…
Matched conditions: HERPES ZOSTER
Sponsor: GlaxoSmithKline • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:57 UTC